Pzena Investment Management LLC Sells 721,663 Shares of Envista Holdings Corporation $NVST

Posted by on Jul 2nd, 2026

Pzena Investment Management LLC trimmed its stake in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 31.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,604,196 shares of the company’s stock after selling 721,663 shares during the period. Pzena Investment Management LLC owned approximately 0.98% of Envista worth $40,698,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Caitong International Asset Management Co. Ltd raised its position in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its position in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the last quarter. UMB Bank n.a. boosted its position in Envista by 46.1% in the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after buying an additional 636 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the period. Finally, IFP Advisors Inc increased its stake in shares of Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares during the period.

Envista Stock Performance

NVST stock opened at $27.21 on Thursday. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. The firm has a market cap of $4.43 billion, a PE ratio of 66.37, a P/E/G ratio of 1.49 and a beta of 0.86. The business’s 50-day moving average price is $24.84 and its two-hundred day moving average price is $25.21.

Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. The company had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.03 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company’s revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, research analysts forecast that Envista Holdings Corporation will post 1.42 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on NVST. Barclays decreased their price target on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Citigroup assumed coverage on shares of Envista in a research report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price on the stock. Morgan Stanley raised their target price on shares of Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Finally, Weiss Ratings cut shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, Envista currently has an average rating of “Hold” and a consensus target price of $28.67.

Get Our Latest Research Report on Envista

Envista Profile

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.